Founded on 21 September 1917 in Helsinki, Finland, by pharmacists Onni Turpeinen, Wikki Walkama, and Eemil Tuurala, Orion Corporation has developed into a globally operating Finnish pharmaceutical company with a long record of scientific expertise and industrial capability. Headquartered in Espoo, the company develops, manufactures, and markets human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining innovative medicines with branded products, generics, consumer health products, and animal health solutions. Orion operates in more than 35 countries, maintains research and development sites in Finland, the United Kingdom, and the United States, and had 4,029 employees at the end of 2025. In 2025, the company reported net sales of EUR 1.89 billion, reflecting the scale and resilience of a business that continues to build on its Nordic heritage and strong position in European healthcare.
Updated 2026-03-19